Jennison Associates
ADVM

Jennison Associates’s Adverum Biotechnologies ADVM Stock Holding History

Jennison Associates’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-30,208
Closed -$1.06M – 652
2017
Q4 		$1.06M Buy
+30,208
New +$994K ﹤0.01% 576
2015
Q2 		– Sell
-7,848
Closed -$3.18M – 730
2015
Q1 		$3.18M Buy
7,848
+25
+0.3% +$10.6K ﹤0.01% 556
2014
Q4 		$4.22M Sell
7,823
-2,177
-22% -$839K ﹤0.01% 518
2014
Q3 		$3.42M Buy
+10,000
New +$2.98M ﹤0.01% 537

Other funds holding ADVM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HCM
Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $48.2B AUM 24.23% 1-Year Est. Return